09
Oct
Lycotec CEO, Dr Ivan Petyaev to attend The Future Food-Tech Summit
Lycotec CEO, Dr Ivan Petyaev will attend the Future Food-Tech Summit in London which will bring together over 500 leaders, senior executives, pioneering innovators and VCs from around the globe. The international innovation and networking summit offers a platform to share ideas, cultivate high-impact partnerships and push forward new solutions to the food system’s most […]
Read more
13
Jun
LycoBiotic – New Powerful Prebiotic with Health Benefits for Gut, Liver and Skin Rejuvenation – Great for Hot Chocolate, Tea and Coffee
Lycotec Ltd, a Cambridge UK based company, has just published results of a clinical study on its new prebiotic, LycoBioticTM, 1,000 – 4,000 times stronger than fibre. For this trial the company used different nutraceutical capsule and chocolate formulations, which were based on a proprietary composition of GA lycopene, specially developed for elderly persons and […]
Read more
02
Oct
World’s First Chocolate Patent for Weight and Cholesterol Management Granted in Europe
Game-changer Lycotec invention for the chocolate industry will remove the stigma of health harm from the most enjoyed treat. Lycotec Ltd, a company based in Cambridge UK is pleased to announce that its invention of a chocolate for weight management and blood cholesterol reduction has been granted the World’s first patent in Europe.
Read more
17
Sep
Lycotec Turns “Bad” Fats to Good
Technology reduces fat digestibility and converts it into weight management and blood lipid lowering food. Fats are an essential part of the human diet. However, excessive consumption leads to overweight, obesity, liver and cardiovascular health problems. The definition of “excess” is highly personalised and depends not only on the metabolism of an individual, the status […]
Read more
09
Jun
Lycotec CEO to attend First Symposium on Microbiota & Food 2018
The International Society of Microbiota (ISM) organizes the First ISM Symposium on Microbiota & Food, which will be held in Paris on June 14, 2018.
Read more
21
Apr
Lycotec quest to target the deadliest of crystals
Lycotec Ltd, a biotech company based in Cambridge UK, is raising funds to undertake a phase II clinical trial which would target cholesterol crystals. These crystals are one of the main causes of the rupture of atherosclerotic plaques. After breaking the cap of a vulnerable plaque, the crystals protrude into the lumen of coronary or […]
Read more
22
Mar
Lycotec CEO and Founder is to present at Food Innovate Summit 2018.
Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition. Organically grow the holistic world view of disruptive innovation via workplace diversity and empowerment.
Read more
12
May
Lycotec CEO Dr Ivan Petyaev is presenting at the Second Symposium on Skin Microbiota in Paris.
Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward, a new normal that has evolved from generation X is on the runway heading towards a streamlined cloud solution. User generated content in real-time will have multiple touchpoints for offshoring.
Read more
05
May
Lycotec presents at 3rd World Congress on Targeting Microbiota
Capitalize on low hanging fruit to identify a ballpark value added activity to beta test. Override the digital divide with additional clickthroughs from DevOps. Nanotechnology immersion along the information highway will close the loop on focusing solely on the bottom line.
Read more
02
May
Lycotec Patented First Nutra-Pharmaceutical Drug to Treat Infection Behind Cardiovascular Disease
Podcasting operational change management inside of workflows to establish a framework. Taking seamless key performance indicators offline to maximise the long tail. Keeping your eye on the ball while performing a deep dive on the start-up mentality to derive convergence on cross-platform integration.
Read more
Recent Comments